Blue Trust’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$412K Buy
3,394
+138
+4% +$16.3K ﹤0.01% 541
2026
Q2
$329K Buy
3,256
+177
+6% +$18.3K ﹤0.01% 626
2026
Q1
$298K Buy
3,079
+346
+13% +$35.5K ﹤0.01% 652
2025
Q4
$290K Sell
2,733
-363
-12% -$42.1K ﹤0.01% 663
2025
Q3
$393K Buy
3,096
+458
+17% +$54.5K ﹤0.01% 577
2025
Q2
$324K Buy
2,638
+648
+33% +$74K ﹤0.01% 609
2025
Q1
$202K Buy
1,990
+517
+35% +$50.5K ﹤0.01% 707
2024
Q4
$136K Buy
1,473
+1,332
+945% +$131K ﹤0.01% 795
2024
Q3
$12.1K Buy
141
+78
+124% +$7.01K ﹤0.01% 2122
2024
Q2
$5.2K Buy
+63
New +$5.29K ﹤0.01% 2189
2024
Q1
– Sell
-183
Closed -$12K – 2335
2023
Q4
$12K Buy
+183
New +$11.9K ﹤0.01% 1512
2023
Q2
– Sell
-29
Closed -$2K – 2146
2023
Q1
$2K Buy
+29
New +$1.69K ﹤0.01% 1995
2022
Q3
– Sell
-2,063
Closed -$117K – 2152
2022
Q2
$117K Buy
+2,063
New +$106K ﹤0.01% 453

Other funds holding EHC

Blue Trust's EHC Position: Q3 2026 in Review

Blue Trust increased its Encompass Health (EHC) stake by 4.2% in Q3 2026, buying an estimated $16.3K and bringing the position to 3,394 shares worth $412K. The position accounts for ﹤0.01% of the portfolio, ranked #541.

Blue Trust first reported a position in EHC in Q2 2022 and has held it in 13 quarters since. 508 funds tracked by Wall St. Rank hold EHC as of Q3 2026.

  • Blue Trust held 3,394 shares of Encompass Health worth $412K as of Q3 2026.
  • Blue Trust bought 138 Encompass Health shares in Q3 2026, an estimated $16.3K.
  • Encompass Health made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #541 holding.
  • Blue Trust first reported a position in Encompass Health in Q2 2022 and has held it in 13 quarters since.
  • 508 funds tracked by Wall St. Rank held Encompass Health as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.